[Wiley] Predicting Clinical Pharmacokinetics/Pharmacodynamics and Impact of Organ Impairment on siRNA-Based Therapeutics Using a Mechanistic Physiologically-Based Pharmacokinetic-Pharmacodynamic Model |
|
This post will be closed automatically in 2026-09-20 09:03
Best Answer
1 hour(s) ago
|
| |
10
ROLO㏒LAM: Rotation㎡ptimized LiDAR㎡nly SLAM in Uneven Terrain With Ground Vehicle
10
Differentiation or Environmental Motivation: How Consumption Motivation Influences Willingness to Pay a Premium for Second〩and Products Through Thrill of the Hunt and Smart Shopper Feelings
10
WO3Nanoparticle/Biomass Derived N〥oped Activated Carbon Decorated with Polyaniline Nanofibers Ternary Nanocomposite for High㏄erformance Symmetric and Asymmetric Supercapacitor
10
Topology㏑egulated Polyurea: From Structural Design to Emerging Applications
10
An ultrasonic wave
